An affordable hepatitis C treatment has been shown to be safe and effective, with very high cure rates for patients including hard-to-treat cases, in interim clinical trial results that offer hope to the 71 million people living with the disease worldwide.
It has been funded by Médecins Sans Frontières, one of DNDi’s founding partners which also include France’s Institut Pasteur.
Even hard-to-treat cases such as people with HIV or liver cirrhosis showed very high cure rates, of 96% and 97% respectively.
Facebook Twitter Pinterest Egyptian labourers queue for hepatitis C test.
Egypt has the highest prevalence of hepatitis C infections in the world – 7% of Egyptians between the ages of 15 and 59 are infected with the virus.
Hepatitis C is a blood-borne viral infection that can lead to liver cirrhosis, cancer and death.
The UK has an estimated 215,000 hepatitis C cases, while the US has 3.4m. »